Cargando…
Pharmacokinetic and Toxicodynamic Characterization of a Novel Doxorubicin Derivative
Doxorubicin (Dox) is an effective anti-cancer medication with poor oral bioavailability and systemic toxicities. DoxQ was developed by conjugating Dox to the lymphatically absorbed antioxidant quercetin to improve Dox’s bioavailability and tolerability. The purpose of this study was to characterize...
Autores principales: | Alrushaid, Samaa, Sayre, Casey L., Yáñez, Jaime A., Forrest, M. Laird, Senadheera, Sanjeewa N., Burczynski, Frank J., Löbenberg, Raimar, Davies, Neal M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620576/ https://www.ncbi.nlm.nih.gov/pubmed/28902176 http://dx.doi.org/10.3390/pharmaceutics9030035 |
Ejemplares similares
-
Stereospecific pharmacokinetic characterization of liquiritigenin in the rat
por: Alrushaid, Samaa, et al.
Publicado: (2017) -
Pharmacological characterization of liquiritigenin, a chiral flavonoid in licorice
por: Alrushaid, Samaa, et al.
Publicado: (2016) -
DOX-Vit D, a Novel Doxorubicin Delivery Approach, Inhibits Human Osteosarcoma Cell Proliferation by Inducing Apoptosis While Inhibiting Akt and mTOR Signaling Pathways
por: Maayah, Zaid H., et al.
Publicado: (2018) -
Semi-Mechanism-Based Pharmacokinetic-Toxicodynamic Model of Oxaliplatin-Induced Acute and Chronic Neuropathy
por: Kobuchi, Shinji, et al.
Publicado: (2020) -
Therapeutic Potential and Predictive Pharmaceutical Modeling of Stilbenes in Cannabis sativa
por: O’Croinin, Conor, et al.
Publicado: (2023)